View More Recent Stories

May 12, 2021 07:00AM Immunocore Reports First Quarter 2021 Financial Results
Apr 28, 2021 04:30PM Immunocore Announces Upcoming Presentations at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
Apr 28, 2021 04:30PM Immunocore Announces Upcoming Presentations at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
Apr 12, 2021 04:35PM Immunocore (IMCR) presents phase 3 data comparing tebentafusp with investigator’s choice in the clinical trial plenary session at AACR
Apr 12, 2021 04:30PM Immunocore presents phase 3 data comparing tebentafusp with investigator’s choice in the clinical trial plenary session at the American Association for Cancer Research 2021 Annual Meeting
Apr 12, 2021 04:30PM Immunocore presents phase 3 data comparing tebentafusp with investigator’s choice in the clinical trial plenary session at the American Association for Cancer Research 2021 Annual Meeting
Mar 25, 2021 07:00AM Immunocore Provides Business Update and Reports Full Year 2020 Financial Results
Mar 25, 2021 07:00AM Immunocore Provides Business Update and Reports Full Year 2020 Financial Results
Mar 24, 2021 05:00AM Mission Therapeutics Welcomes Co-founder of Rosetta Capital, Jonathan Hepple, to its Board of Directors
Mar 10, 2021 07:00PM Immunocore Announces Upcoming Presentations at the American Association for Cancer Research (AACR) 2021 Annual Meeting
Feb 19, 2021 07:00AM Immunocore’s tebentafusp granted Breakthrough Therapy Designation for unresectable or metastatic uveal melanoma from FDA
Feb 16, 2021 07:00AM Immunocore announces key appointments to management and Board
Feb 16, 2021 07:00AM Immunocore announces key appointments to management and Board
Feb 10, 2021 04:00AM Citi Appointed as Depositary Bank for Immunocore Holdings plc’s ADR Programme
View More Recent Stories